Human Holdings Co (2415) Q3 2025 earnings summary

Executive summary

• Revenue/net sales for the nine months ended December 31, 2024, increased 4.9% year-over-year to ¥74,934 million.

• Operating profit rose 10.7% to ¥2,248 million, ordinary profit up 14.1% to ¥2,374 million, and net profit attributable to shareholders increased 21.2% to ¥1,450 million.

• Earnings per share for the period were ¥139.75, up from ¥111.12 in the prior year.

Financial highlights

• Gross profit for the nine months was ¥19,190 million, up from ¥18,185 million year-over-year.

• Selling, general and administrative expenses increased to ¥16,941 million from ¥16,153 million.

• Extraordinary income included a gain on sale of businesses of ¥140 million.

• Total assets as of December 31, 2024, were ¥50,911 million, with net assets at ¥16,936 million.

• Equity ratio improved to 33.3% as of December 2024.

Outlook and guidance

• Full-year revenue/net sales forecast at ¥99,300 million (+3.6% YoY), operating profit at ¥3,300 million (+4.8% YoY), and net profit at ¥2,200 million (+2.0% YoY), all expected to reach record highs.

• Full-year earnings per share expected to reach ¥211.99.

• No revision to previously announced guidance.